US Patent Issued to Dana-Farber Cancer Institute, President and Fellows of Harvard College on Oct. 14 for "BCL-W polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss" (Massachusetts, New Hampshire Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,775, issued on Oct. 14, was assigned to Dana-Farber Cancer Institute Inc. (Boston) and President and Fellows of Harvard College (Cambridge, Mass.).

"BCL-W polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss" was invented by Rosalind Segal (Brookline, Mass.), Loren D. Walensky (Newton, Mass.), Lisa V. Goodrich (Newton, Mass.), Sarah Elizabeth Raissi (Waltham, Mass.), Maria F. Murphy (Revere, Mass.) and Gregory H. Bird (Pelham, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods are provided for the treatment or prevention of chemotherapy-induced peripheral neuropath...